Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Neoplasms 1

Interventions

Temozolomide 32 Radiotherapy 11 Bevacizumab 10 Surgical Procedures, Operative 7 IL13-PE38 7 TIC10 compound 6 Lomustine 6 Carboplatin 6 Radiation 5 Chlorotoxin 5 vorasidenib 4 trametinib 4 dabrafenib 4 Valacyclovir 4 OKN 007 4 Flucytosine 4 Dianhydrogalactitol 4 Cyclophosphamide 4 vocimagene amiretrorepvec 3 abemaciclib 3 Paclitaxel 3 Nivolumab 3 Irinotecan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 CLR1404 3 trans-sodium crocetinate 2 pembrolizumab 2 olutasidenib 2 marizomib 2 lenvatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Glioma × Drug Tolerance × Clear all

NCT04771897 2024-12-20

KONQUER

Bexion Pharmaceuticals, Inc.

Phase 1 Terminated

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡